ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Association of the Triglyceride Glucose Index and Epicardial Adipose Tissue with Type 2 Diabetes Mellitus Complicated by Coronary Atherosclerotic Heart Disease.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To examine the role of the triglyceride glucose(TyG) index and epicardial adipose tissue(EAT) in the progression of type 2 diabetes mellitus (T2DM) with concurrent coronary atherosclerotic heart disease(CHD), thereby establishing a theoretical foundation for early clinical intervention in CHD among T2DM patients. Methods: This retrospective study analysed 96 patients with T2DM who underwent Coronary CT angiography at the Department of Endocrinology, Qinhuangdao First Hospital, between January 2020 and June 2023. Participants were categorised into two groups: those with T2DM and CHD (n=48) and those with T2DM alone (n=48). Clinical indicators were compared between the groups. Logistic regression analysis assessed the association between T2DM with CHD and both the TyG index and EAT. Receiver operating characteristic (ROC) curve analysis evaluated the predictive value of these parameters. Results: Significant differences (P < 0.05) were found between the two groups in weight, uric acid(UA), triglycerides(TG), high-density lipoprotein cholesterol (HDL-C), epicardial adipose tissue volume (EATV) and the TyG index. Multivariate analysis identified both EATV and the TyG index as independent risk factors for T2DM complicated by CHD (P < 0.05). ROC curve analysis demonstrated that both EATV and TyG index showed statistically significant predictive power for CHD development in T2DM patients (P<0.05). The EATV exhibited an AUC of 0.739 with a predictive cut-off value of 128.45 mL (sensitivity 66.7%, specificity 72.9%). The TyG index demonstrated an AUC of 0.724 with a predictive cut-off value of 9.47 (sensitivity 58.3%, specificity 81.2%). Conclusion: The TyG index and EAT are significant risk factors for CHD in T2DM patients. These findings provide a theoretical basis for early screening, monitoring, and clinical intervention in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.